AMINO, Polifarma Sign Licensing Agreement

September 23, 2002

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal


AMINO, Polifarma Sign Licensing Agreement

FRELLSTEDT, Germany--AMINO signed a licensingagreement with Polifarma SpA in Rome for AMINO's use of uridine in nutritionaland pharmaceutical applications worldwide. Uridine has been shown to beeffective in treating neurogenerative disorders, depression, arthritis and more,according to AMINO (www.amino.de). Bothcompanies have studied the use of uridine for many years; the agreement willhave AMINO leading marketing efforts supported by R&D expertise fromPolifarma.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like